Clinical Trial Detail

NCT ID NCT04337099
Title A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
Recruitment Available
Gender male
Phase Expanded access
Variant Requirements No
Sponsors Matrix Biomed, Inc.
Indications

prostate cancer

Therapies

Tempol

Age Groups: adult senior

No variant requirements are available.